Full Text View
Tabular View
No Study Results Posted
Related Studies
Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver
This study has been terminated.
Study NCT00274495   Information provided by Beth Israel Medical Center

First Received on January 9, 2006.   Last Updated on October 31, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial